Literature DB >> 6141537

Cholecystokinin in the central nervous system: a minireview.

M C Beinfeld.   

Abstract

This review focuses on the structure, distribution, neuronal pathways, receptor binding, release, biosynthesis and degradation of CCK in the central nervous system. Other aspects of the isolation and chemistry of CCK (1), its role in satiety (2), as a hormone or neurotransmitter (3,4), and its evolution (5) have been reviewed recently.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6141537     DOI： 10.1016/0143-4179(83)90032-x

Source DB:  PubMed          Journal:  Neuropeptides        ISSN： 0143-4179            Impact factor:   3.286


  19 in total

1.  CCK-immunoreactive terminals form different types of synapses in the rat and monkey hippocampus.

Authors:  C Leranth; M Frotscher; P Rakic
Journal:  Histochemistry       Date:  1988

2.  Interaction between cholecystokinin and the fibroblast growth factor system in the ventral tegmental area of selectively bred high- and low-responder rats.

Authors:  S J Ballaz; J Perez; M Waselus; H Akil; S J Watson
Journal:  Neuroscience       Date:  2013-10-09       Impact factor: 3.590

3.  Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022.

Authors:  M Kitano; P Norlén; X Q Ding; S Nakamura; R Håkanson
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

4.  Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.

Authors:  B E Evans; M G Bock; K E Rittle; R M DiPardo; W L Whitter; D F Veber; P S Anderson; R M Freidinger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment.

Authors:  J Harro; M Põld; E Vasar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

6.  Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells.

Authors:  E Lindström; M Björkqvist; R Håkanson
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

7.  GABAergic input of cholecystokinin-immunoreactive neurons in the hilar region of the rat hippocampus. An electron microscopic double immunostaining study.

Authors:  C Leranth; M Frotscher
Journal:  Histochemistry       Date:  1987

8.  A serine peptidase responsible for the inactivation of endogenous cholecystokinin in brain.

Authors:  C Rose; A Camus; J C Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

9.  Few cortical cholecystokinin immunoreactive neurons have long projections.

Authors:  K B Seroogy; J H Fallon; S E Loughlin; F M Leslie
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

10.  Influences of cholecystokinin octapeptide on phosphoinositide turnover in neonatal-rat brain cells.

Authors:  L J Zhang; X Y Lu; J S Han
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.